Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Completed · Phase 3 · Has a placebo group

Conditions studied: Recurrent Pericarditis

In brief

The primary objective of this study was to assess the efficacy of rilonacept treatment in participants with recurrent pericarditis.

Key facts

Study ID
NCT03737110
Run by
Kiniksa Pharmaceuticals (UK), Ltd.
People needed
86
Starts
2019-01-07
Expected to finish
2022-06-30
Last updated by the study team
2023-09-06

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.